nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP1A2—chronic obstructive pulmonary disease	0.468	1	CbGaD
Rotigotine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0459	0.15	CbGbCtD
Rotigotine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0445	0.145	CbGbCtD
Rotigotine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0445	0.145	CbGbCtD
Rotigotine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0396	0.129	CbGbCtD
Rotigotine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0373	0.122	CbGbCtD
Rotigotine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0252	0.0821	CbGbCtD
Rotigotine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.024	0.0783	CbGbCtD
Rotigotine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0214	0.0698	CbGbCtD
Rotigotine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0126	0.041	CbGbCtD
Rotigotine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0119	0.0387	CbGbCtD
Rotigotine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00263	CcSEcCtD
Rotigotine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.00261	CcSEcCtD
Rotigotine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000406	0.00261	CcSEcCtD
Rotigotine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000405	0.00261	CcSEcCtD
Rotigotine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000403	0.00259	CcSEcCtD
Rotigotine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000403	0.00259	CcSEcCtD
Rotigotine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000401	0.00258	CcSEcCtD
Rotigotine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.00257	CcSEcCtD
Rotigotine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000399	0.00257	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000397	0.00255	CcSEcCtD
Rotigotine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000396	0.00254	CcSEcCtD
Rotigotine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.00254	CcSEcCtD
Rotigotine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000395	0.00254	CcSEcCtD
Rotigotine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000394	0.00253	CcSEcCtD
Rotigotine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00253	CcSEcCtD
Rotigotine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00253	CcSEcCtD
Rotigotine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000391	0.00251	CcSEcCtD
Rotigotine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00251	CcSEcCtD
Rotigotine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000388	0.0025	CcSEcCtD
Rotigotine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000388	0.0025	CcSEcCtD
Rotigotine—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000387	0.00249	CcSEcCtD
Rotigotine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000387	0.00249	CcSEcCtD
Rotigotine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000385	0.00248	CcSEcCtD
Rotigotine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.00246	CcSEcCtD
Rotigotine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.00245	CcSEcCtD
Rotigotine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.00242	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000376	0.00242	CcSEcCtD
Rotigotine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000376	0.00241	CcSEcCtD
Rotigotine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000376	0.00241	CcSEcCtD
Rotigotine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.0024	CcSEcCtD
Rotigotine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000372	0.00239	CcSEcCtD
Rotigotine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00239	CcSEcCtD
Rotigotine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00239	CcSEcCtD
Rotigotine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00239	CcSEcCtD
Rotigotine—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00037	0.00238	CcSEcCtD
Rotigotine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000368	0.00236	CcSEcCtD
Rotigotine—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000368	0.00236	CcSEcCtD
Rotigotine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000367	0.00236	CcSEcCtD
Rotigotine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.00236	CcSEcCtD
Rotigotine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00236	CcSEcCtD
Rotigotine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00236	CcSEcCtD
Rotigotine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00235	CcSEcCtD
Rotigotine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00234	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00234	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00234	CcSEcCtD
Rotigotine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000362	0.00233	CcSEcCtD
Rotigotine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000362	0.00233	CcSEcCtD
Rotigotine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000359	0.00231	CcSEcCtD
Rotigotine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000358	0.0023	CcSEcCtD
Rotigotine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.0023	CcSEcCtD
Rotigotine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.0023	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00229	CcSEcCtD
Rotigotine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000355	0.00228	CcSEcCtD
Rotigotine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00226	CcSEcCtD
Rotigotine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00224	CcSEcCtD
Rotigotine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00224	CcSEcCtD
Rotigotine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00222	CcSEcCtD
Rotigotine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000346	0.00222	CcSEcCtD
Rotigotine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00221	CcSEcCtD
Rotigotine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00221	CcSEcCtD
Rotigotine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.0022	CcSEcCtD
Rotigotine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000342	0.0022	CcSEcCtD
Rotigotine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000341	0.00219	CcSEcCtD
Rotigotine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.00219	CcSEcCtD
Rotigotine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00034	0.00219	CcSEcCtD
Rotigotine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00218	CcSEcCtD
Rotigotine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00217	CcSEcCtD
Rotigotine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000334	0.00215	CcSEcCtD
Rotigotine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00212	CcSEcCtD
Rotigotine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00211	CcSEcCtD
Rotigotine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00211	CcSEcCtD
Rotigotine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000327	0.0021	CcSEcCtD
Rotigotine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.0021	CcSEcCtD
Rotigotine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.00209	CcSEcCtD
Rotigotine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00209	CcSEcCtD
Rotigotine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.00207	CcSEcCtD
Rotigotine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000321	0.00206	CcSEcCtD
Rotigotine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00206	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00032	0.00206	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.00206	CcSEcCtD
Rotigotine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000318	0.00204	CcSEcCtD
Rotigotine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.00204	CcSEcCtD
Rotigotine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00203	CcSEcCtD
Rotigotine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000316	0.00203	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000313	0.00202	CcSEcCtD
Rotigotine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.00201	CcSEcCtD
Rotigotine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000312	0.00201	CcSEcCtD
Rotigotine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000311	0.002	CcSEcCtD
Rotigotine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00199	CcSEcCtD
Rotigotine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00199	CcSEcCtD
Rotigotine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00199	CcSEcCtD
Rotigotine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000309	0.00199	CcSEcCtD
Rotigotine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000308	0.00198	CcSEcCtD
Rotigotine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000306	0.00197	CcSEcCtD
Rotigotine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000305	0.00196	CcSEcCtD
Rotigotine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000304	0.00196	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.00195	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000303	0.00195	CcSEcCtD
Rotigotine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00195	CcSEcCtD
Rotigotine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000303	0.00195	CcSEcCtD
Rotigotine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.00195	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00194	CcSEcCtD
Rotigotine—Pain—Formoterol—chronic obstructive pulmonary disease	0.0003	0.00193	CcSEcCtD
Rotigotine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.0003	0.00193	CcSEcCtD
Rotigotine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.0003	0.00193	CcSEcCtD
Rotigotine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.0003	0.00193	CcSEcCtD
Rotigotine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00193	CcSEcCtD
Rotigotine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.00191	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00191	CcSEcCtD
Rotigotine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00191	CcSEcCtD
Rotigotine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.0019	CcSEcCtD
Rotigotine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000294	0.00189	CcSEcCtD
Rotigotine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000293	0.00189	CcSEcCtD
Rotigotine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00188	CcSEcCtD
Rotigotine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000291	0.00187	CcSEcCtD
Rotigotine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000291	0.00187	CcSEcCtD
Rotigotine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000289	0.00186	CcSEcCtD
Rotigotine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.00186	CcSEcCtD
Rotigotine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000289	0.00186	CcSEcCtD
Rotigotine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.00185	CcSEcCtD
Rotigotine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000288	0.00185	CcSEcCtD
Rotigotine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000287	0.00185	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00184	CcSEcCtD
Rotigotine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00184	CcSEcCtD
Rotigotine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.00182	CcSEcCtD
Rotigotine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.00182	CcSEcCtD
Rotigotine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000279	0.00179	CcSEcCtD
Rotigotine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.00179	CcSEcCtD
Rotigotine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000277	0.00178	CcSEcCtD
Rotigotine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000275	0.00177	CcSEcCtD
Rotigotine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.00176	CcSEcCtD
Rotigotine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.00176	CcSEcCtD
Rotigotine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000274	0.00176	CcSEcCtD
Rotigotine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000273	0.00176	CcSEcCtD
Rotigotine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00176	CcSEcCtD
Rotigotine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000273	0.00175	CcSEcCtD
Rotigotine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000268	0.00173	CcSEcCtD
Rotigotine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00169	CcSEcCtD
Rotigotine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00166	CcSEcCtD
Rotigotine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00166	CcSEcCtD
Rotigotine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000259	0.00166	CcSEcCtD
Rotigotine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.00166	CcSEcCtD
Rotigotine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000253	0.00163	CcSEcCtD
Rotigotine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00162	CcSEcCtD
Rotigotine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00162	CcSEcCtD
Rotigotine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.0016	CcSEcCtD
Rotigotine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000249	0.0016	CcSEcCtD
Rotigotine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00159	CcSEcCtD
Rotigotine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00157	CcSEcCtD
Rotigotine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00156	CcSEcCtD
Rotigotine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00155	CcSEcCtD
Rotigotine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00155	CcSEcCtD
Rotigotine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00153	CcSEcCtD
Rotigotine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00152	CcSEcCtD
Rotigotine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000235	0.00151	CcSEcCtD
Rotigotine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00151	CcSEcCtD
Rotigotine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000233	0.0015	CcSEcCtD
Rotigotine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00149	CcSEcCtD
Rotigotine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00149	CcSEcCtD
Rotigotine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000228	0.00146	CcSEcCtD
Rotigotine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00146	CcSEcCtD
Rotigotine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000224	0.00144	CcSEcCtD
Rotigotine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00144	CcSEcCtD
Rotigotine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00144	CcSEcCtD
Rotigotine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00142	CcSEcCtD
Rotigotine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00142	CcSEcCtD
Rotigotine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00142	CcSEcCtD
Rotigotine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00142	CcSEcCtD
Rotigotine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00142	CcSEcCtD
Rotigotine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00141	CcSEcCtD
Rotigotine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00141	CcSEcCtD
Rotigotine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.00022	0.00141	CcSEcCtD
Rotigotine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00141	CcSEcCtD
Rotigotine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00141	CcSEcCtD
Rotigotine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00139	CcSEcCtD
Rotigotine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00139	CcSEcCtD
Rotigotine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.00139	CcSEcCtD
Rotigotine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00139	CcSEcCtD
Rotigotine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000216	0.00139	CcSEcCtD
Rotigotine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.00137	CcSEcCtD
Rotigotine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00136	CcSEcCtD
Rotigotine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00021	0.00135	CcSEcCtD
Rotigotine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00135	CcSEcCtD
Rotigotine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00134	CcSEcCtD
Rotigotine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00134	CcSEcCtD
Rotigotine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00134	CcSEcCtD
Rotigotine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00134	CcSEcCtD
Rotigotine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00134	CcSEcCtD
Rotigotine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00134	CcSEcCtD
Rotigotine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.00132	CcSEcCtD
Rotigotine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00131	CcSEcCtD
Rotigotine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00129	CcSEcCtD
Rotigotine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00127	CcSEcCtD
Rotigotine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00126	CcSEcCtD
Rotigotine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00124	CcSEcCtD
Rotigotine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00123	CcSEcCtD
Rotigotine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.0012	CcSEcCtD
Rotigotine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00118	CcSEcCtD
Rotigotine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00113	CcSEcCtD
Rotigotine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00113	CcSEcCtD
Rotigotine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00111	CcSEcCtD
Rotigotine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.0011	CcSEcCtD
Rotigotine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00017	0.0011	CcSEcCtD
Rotigotine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00109	CcSEcCtD
Rotigotine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00109	CcSEcCtD
Rotigotine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00105	CcSEcCtD
Rotigotine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00101	CcSEcCtD
Rotigotine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00101	CcSEcCtD
Rotigotine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000156	0.001	CcSEcCtD
Rotigotine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000995	CcSEcCtD
Rotigotine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000982	CcSEcCtD
Rotigotine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000978	CcSEcCtD
Rotigotine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000976	CcSEcCtD
Rotigotine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000972	CcSEcCtD
Rotigotine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000957	CcSEcCtD
Rotigotine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00094	CcSEcCtD
Rotigotine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000927	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000921	CcSEcCtD
Rotigotine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000916	CcSEcCtD
Rotigotine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.000901	CcSEcCtD
Rotigotine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000883	CcSEcCtD
Rotigotine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000874	CcSEcCtD
Rotigotine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000871	CcSEcCtD
Rotigotine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000863	CcSEcCtD
Rotigotine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000859	CcSEcCtD
Rotigotine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000847	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00081	CcSEcCtD
Rotigotine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000809	CcSEcCtD
Rotigotine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000804	CcSEcCtD
Rotigotine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000798	CcSEcCtD
Rotigotine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000782	CcSEcCtD
Rotigotine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000773	CcSEcCtD
Rotigotine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000771	CcSEcCtD
Rotigotine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.00077	CcSEcCtD
Rotigotine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000766	CcSEcCtD
Rotigotine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000766	CcSEcCtD
Rotigotine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00076	CcSEcCtD
Rotigotine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000732	CcSEcCtD
Rotigotine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000726	CcSEcCtD
Rotigotine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000706	CcSEcCtD
Rotigotine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000655	CcSEcCtD
Rotigotine—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.92e-05	0.000638	CcSEcCtD
Rotigotine—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.78e-05	0.000629	CcSEcCtD
Rotigotine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.46e-05	0.000608	CcSEcCtD
Rotigotine—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.14e-05	0.000588	CcSEcCtD
Rotigotine—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.000565	CcSEcCtD
Rotigotine—Rash—Prednisone—chronic obstructive pulmonary disease	8.72e-05	0.00056	CcSEcCtD
Rotigotine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.71e-05	0.00056	CcSEcCtD
Rotigotine—Headache—Prednisone—chronic obstructive pulmonary disease	8.66e-05	0.000557	CcSEcCtD
Rotigotine—Nausea—Prednisone—chronic obstructive pulmonary disease	8.21e-05	0.000528	CcSEcCtD
Rotigotine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	3.69e-05	0.000528	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.68e-05	0.000526	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.63e-05	0.000519	CbGpPWpGaD
Rotigotine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.62e-05	0.000517	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—NOS2—chronic obstructive pulmonary disease	3.58e-05	0.000512	CbGpPWpGaD
Rotigotine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.57e-05	0.000511	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.56e-05	0.000509	CbGpPWpGaD
Rotigotine—DRD4—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.56e-05	0.000509	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.55e-05	0.000507	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.54e-05	0.000506	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.53e-05	0.000505	CbGpPWpGaD
Rotigotine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.53e-05	0.000504	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.53e-05	0.000504	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.42e-05	0.000489	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.4e-05	0.000487	CbGpPWpGaD
Rotigotine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.39e-05	0.000485	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.38e-05	0.000483	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.37e-05	0.000481	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.36e-05	0.00048	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.35e-05	0.000479	CbGpPWpGaD
Rotigotine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.34e-05	0.000478	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.34e-05	0.000477	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.32e-05	0.000475	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.3e-05	0.000473	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.28e-05	0.000469	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.25e-05	0.000465	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.22e-05	0.000461	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.2e-05	0.000458	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.2e-05	0.000458	CbGpPWpGaD
Rotigotine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.17e-05	0.000454	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.16e-05	0.000452	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.16e-05	0.000452	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.04e-05	0.000435	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.03e-05	0.000433	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.02e-05	0.000433	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.01e-05	0.000431	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—ALB—chronic obstructive pulmonary disease	3.01e-05	0.00043	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3e-05	0.000429	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3e-05	0.000429	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.98e-05	0.000427	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.95e-05	0.000423	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.93e-05	0.000419	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.93e-05	0.000418	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.89e-05	0.000413	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.88e-05	0.000412	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.88e-05	0.000411	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.85e-05	0.000408	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.85e-05	0.000408	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.83e-05	0.000405	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.78e-05	0.000397	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.76e-05	0.000395	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.75e-05	0.000394	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.75e-05	0.000394	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.73e-05	0.00039	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.72e-05	0.00039	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.71e-05	0.000387	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.7e-05	0.000387	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.69e-05	0.000384	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.66e-05	0.00038	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.62e-05	0.000375	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.61e-05	0.000374	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.61e-05	0.000373	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.6e-05	0.000372	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.57e-05	0.000367	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.54e-05	0.000364	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.53e-05	0.000362	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.52e-05	0.00036	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.52e-05	0.00036	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.5e-05	0.000357	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.47e-05	0.000354	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.46e-05	0.000351	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.42e-05	0.000346	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.42e-05	0.000346	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.42e-05	0.000346	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.37e-05	0.000339	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.36e-05	0.000338	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.34e-05	0.000335	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.34e-05	0.000335	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.31e-05	0.000331	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.3e-05	0.000328	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.29e-05	0.000327	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.28e-05	0.000326	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.23e-05	0.000319	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.21e-05	0.000316	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.2e-05	0.000314	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.18e-05	0.000311	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.15e-05	0.000307	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.12e-05	0.000303	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.09e-05	0.000298	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.07e-05	0.000296	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.01e-05	0.000288	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.01e-05	0.000287	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.01e-05	0.000287	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.01e-05	0.000287	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.99e-05	0.000285	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.98e-05	0.000284	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.94e-05	0.000277	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.9e-05	0.000272	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.87e-05	0.000268	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.83e-05	0.000261	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.81e-05	0.000259	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.81e-05	0.000259	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.81e-05	0.000259	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.81e-05	0.000258	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.8e-05	0.000257	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.79e-05	0.000256	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.79e-05	0.000255	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.77e-05	0.000253	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.77e-05	0.000253	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.76e-05	0.000251	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.75e-05	0.00025	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.73e-05	0.000247	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.73e-05	0.000247	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.69e-05	0.000241	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.65e-05	0.000236	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.64e-05	0.000235	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.64e-05	0.000235	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.63e-05	0.000234	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.63e-05	0.000233	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.62e-05	0.000232	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.62e-05	0.000232	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.61e-05	0.000231	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.61e-05	0.00023	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.6e-05	0.000229	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.57e-05	0.000225	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	1.57e-05	0.000224	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.000223	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.55e-05	0.000222	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.54e-05	0.000221	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.52e-05	0.000217	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.47e-05	0.00021	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.46e-05	0.000209	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.46e-05	0.000209	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.46e-05	0.000209	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.45e-05	0.000208	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.45e-05	0.000208	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.44e-05	0.000206	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.41e-05	0.000202	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.4e-05	0.000201	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.4e-05	0.0002	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.39e-05	0.000199	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.37e-05	0.000195	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.36e-05	0.000194	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.35e-05	0.000193	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.33e-05	0.000191	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.32e-05	0.000189	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.32e-05	0.000189	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.3e-05	0.000186	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.27e-05	0.000182	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.26e-05	0.00018	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.24e-05	0.000178	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.24e-05	0.000177	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.23e-05	0.000176	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.23e-05	0.000176	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.22e-05	0.000174	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.22e-05	0.000174	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.000172	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.19e-05	0.00017	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.19e-05	0.00017	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.18e-05	0.000169	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.15e-05	0.000164	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.15e-05	0.000164	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.13e-05	0.000162	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.12e-05	0.00016	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.1e-05	0.000158	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.09e-05	0.000157	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.09e-05	0.000156	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.08e-05	0.000154	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.08e-05	0.000154	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.07e-05	0.000153	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.07e-05	0.000153	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.03e-05	0.000148	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.03e-05	0.000147	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.02e-05	0.000146	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.02e-05	0.000146	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1e-05	0.000144	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.86e-06	0.000141	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.75e-06	0.000139	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.75e-06	0.000139	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.71e-06	0.000139	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.6e-06	0.000137	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.58e-06	0.000137	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.49e-06	0.000136	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.41e-06	0.000135	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.35e-06	0.000134	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.23e-06	0.000132	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.11e-06	0.00013	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.07e-06	0.00013	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.97e-06	0.000128	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.86e-06	0.000127	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.78e-06	0.000126	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.76e-06	0.000125	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.66e-06	0.000124	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.66e-06	0.000124	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.65e-06	0.000124	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.65e-06	0.000124	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.62e-06	0.000123	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.5e-06	0.000122	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.35e-06	0.000119	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.26e-06	0.000118	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.22e-06	0.000118	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.21e-06	0.000117	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.04e-06	0.000115	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.98e-06	0.000114	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.94e-06	0.000114	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.92e-06	0.000113	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.88e-06	0.000113	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.88e-06	0.000113	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.82e-06	0.000112	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.78e-06	0.000111	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.55e-06	0.000108	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.51e-06	0.000107	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.33e-06	0.000105	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.24e-06	0.000103	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.14e-06	0.000102	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.09e-06	0.000101	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.02e-06	0.0001	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7e-06	0.0001	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.97e-06	9.97e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.78e-06	9.7e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.65e-06	9.52e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.63e-06	9.48e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.62e-06	9.46e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.56e-06	9.38e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.45e-06	9.22e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.32e-06	9.04e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.22e-06	8.9e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.11e-06	8.74e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.1e-06	8.73e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.06e-06	8.66e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	6.03e-06	8.62e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.96e-06	8.52e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.95e-06	8.51e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.88e-06	8.41e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.8e-06	8.29e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.76e-06	8.24e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.46e-06	7.81e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.45e-06	7.8e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.38e-06	7.7e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.36e-06	7.66e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.31e-06	7.59e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.12e-06	7.33e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	5.1e-06	7.3e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.88e-06	6.98e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.86e-06	6.95e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.69e-06	6.71e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.5e-06	6.43e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.12e-06	5.89e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.94e-06	5.63e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.77e-06	5.39e-05	CbGpPWpGaD
